$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed analysis of whether Anagrelide is a chemotherapy drug and its pharmacological effects
2026-02-01 22:25:32
Check Details
How many years can apalutamide (Ansenko) be taken and its safety analysis
2026-02-01 22:25:32
Check Details
Why is it recommended that patients use elacestrant as little as possible and risk analysis of drug use
2026-02-01 22:25:32
Check Details
Is the effect of F/TAF as a blocking drug reliable and analysis of relevant clinical data
2026-02-01 22:25:32
Check Details
Causes and treatment methods for worsening of gout symptoms after taking Febuxostat (Febuxostat)
2026-02-01 22:25:32
Check Details
How long does it usually take for patients to become resistant to furmonertinib and analysis of the causes
2026-02-01 22:25:32
Check Details
Summary of clinical efficacy and patient feedback of ensifentrine-Ohtuvayre in the treatment of chronic obstructive pulmonary disease
2026-02-01 22:25:32
Check Details
Analysis of the reasons why people dare not stop taking Roaccutane (isotretinoin) easily after taking it for three years
2026-02-01 22:25:32
Check Details
Comparison of the advantages and disadvantages of whether Doxorubicin or Paclitaxel is more suitable for treating different cancers
2026-02-01 22:25:32
Check Details
Detailed explanation of contraindications and drug risks for patients with Everolimus (Afinitor)
2026-02-01 22:25:32
Check Details
Analysis of the mechanism of action of estramustine and its effect on tumor cells
2026-02-01 22:25:32
Check Details
Whether seripase (BRINEURA) has been included in the medical insurance policy and the introduction of medical insurance reimbursement
2026-02-01 22:25:32
Check Details
1
2
...
2152
2153
2154
2155
2156
2157
2158
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
2
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
3
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
4
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
5
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
6
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
7
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
8
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
9
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
10
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
11
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
12
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment